News

The stock's fall snapped a two-day winning streak.
DHR's Q2 results are likely to reflect Life Sciences weakness, but strength in Biotechnology & Diagnostics units and Abcam acquisition add upside potential.
Shares of Waters Corp. slid 3.16% to $287.53 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.01% to 6,296.79 and Dow Jones ...
More than 25 companies reshuffled technology leadership in the last three months, including Home Depot, McDonald’s and Best ...
The VOO ETF stock price continued to soar this week, as the Fear and Greed Index rose. Explore what to expect as key analyst ...
A daily rundown of the economic reports and corporate earnings that will be grabbing the market’s attention in the week ahead ...
Overview of Prenatal Genetic Testing MarketThe global Prenatal Genetic Testing Market is valued at USD 7.01 Billion in 2024 ...
Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.
Danaher Corporation (DHR) recently disclosed $70,000 in lobbying efforts, focusing on life sciences and biotechnology. This ...